Intragastric Balloons Market Report 2026

Intragastric Balloons Market Overview

• Intragastric Balloons market size has reached to $22.05 billion in 2025 • Expected to grow to $36.1 billion in 2030 at a compound annual growth rate (CAGR) of 10.1% • Growth Driver: Rising Obesity Rates Fuel Expansion Of Intragastric Balloon • Market Trend: Minimally Invasive Endoscopic Solutions For Effective Weight Loss Management • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Intragastric Balloons Market?

Intragastric balloons refer to a minimally invasive bariatric treatment for obesity that involves placing a medical implant in the stomach to restrict its capacity temporarily. This procedure is designed for individuals with obesity, offering a non-surgical option that does not require general anesthesia. The balloons work by taking up space in the stomach, making individuals feel full and limiting their food intake. They are typically inserted using an endoscope, a long, flexible tube with a camera attached, passed through the mouth into the stomach. The main types of intragastric balloons are single, dual, and triple intragastric balloons. A single intragastric balloon refers to a type of medical device used for weight loss in obese patients. The filling materials are categorized into saline-filled and gas-filled, which are distributed through channels such as online pharmacies, retail pharmacies, and hospital pharmacies for use in several application areas, including obesity, diabetes, diet control, weight loss, and pre-operative weight reduction. Others by end users, such as hospitals, clinics, ambulatory surgical centers, and others.

What Is The Intragastric Balloons Market Growth Forecast?

The intragastric balloons market size is expected to see rapid growth in the next few years. It will grow to $36.1 billion in 2030 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to increasing demand for non-surgical obesity treatments, growing incidence of obesity-related comorbidities, rising focus on preventive weight management, expanding availability of endoscopic bariatric procedures, increasing patient preference for reversible weight loss options. Major trends in the forecast period include growing adoption of non-surgical weight loss procedures, rising preference for temporary and reversible bariatric treatments, increasing use of intragastric balloons for pre-operative weight reduction, expansion of intragastric balloon therapy in obesity management programs, growing acceptance of endoscopic weight loss interventions.

Global Intragastric Balloons Market Segmentation

1) By Type: Single, Dual, Triple Intragastric Balloons 2) By Filling Material: Saline Filled, Gas Filled 3) By Application Areas: Obesity, Weight-loss, Pre-operative Weight Reduction, Other Applications 4) By End-User: Hospitals, Clinics, Ambulatory Surgical Centers, Other End-Users Subsegments: 1) By Single Intragastric Balloon: Silicone-Based Single Balloon, Non-silicone-Based Single Balloon 2) By Dual Intragastric Balloon: Silicone-Based Dual Balloon, Non-silicone-Based Dual Balloon 3) By Triple Intragastric Balloon: Silicone-Based Triple Balloon, Non-silicone-Based Triple Balloon

What Is The Driver Of The Intragastric Balloons Market?

The increasing obesity rates are expected to propel the growth of the intragastric balloon market going forward. Obesity rates refer to the prevalence or percentage of a population that is considered obese based on body mass index (BMI) measurements, which is generally defined as having a BMI of 30 or higher. The increasing obesity rates are due to dietary habits, sedentary lifestyles, economic factors, advertising and marketing, genetics and biology, psychological and emotional factors, and urbanization and infrastructure. Obese individuals utilize intragastric balloons as a non-surgical option to aid in weight loss by occupying space in the stomach, promoting feelings of fullness, and reducing food intake. For instance, in March 2023, according to the World Obesity Atlas 2022, published by the World Obesity Federation, a UK-based non-profit organization, the global economic impact of overweight and obesity is projected to reach $4.32 trillion per year by 2035 if prevention and treatment efforts remain unchanged. By that time, over half of the world's population (51%, or more than 4 billion people) could be affected by overweight or obesity, with nearly 2 billion individuals, 1 in 4 people, expected to have obesity if current trends continue. Therefore, the increasing obesity rates are driving the growth of the intragastric balloon industry.

Key Players In The Global Intragastric Balloons Market

Major companies operating in the intragastric balloons market are Apollo Endosurgery Inc., Allurion Technologies Inc., ReShape Lifesciences Inc., Spatz Medical, USGI Medical Inc., Obalon Therapeutics Inc., Bariatric Solutions International GmbH, Helioscopie SA, Silimed GmbH, Endalis, Medsil, Inamed Health, Micro-Tech (Nanjing) Co. Ltd, EndoShape Inc., Medicone Srl, Medicrea Bariatrics, Ethicon Bariatric Technologies, Endomed Systems GmbH, BaroSense Inc., Endolife Technologies

Global Intragastric Balloons Market Trends and Insights

Major companies in the intragastric balloon market are developing advanced solutions, including weight loss medications, to address challenges like dieting difficulties, costs, and fear of surgery. Weight loss medications help reduce body weight by curbing appetite, boosting metabolism, or limiting fat absorption. For instance, in August 2025, Boston Scientific introduced Endura Weight Loss Solutions, offering minimally invasive, endoscopic alternatives to surgery or long-term medication. These include endoscopic sleeve gastroplasty (ESG), which reduces stomach volume by 70–80% via internal stitching, and the Orbera Intragastric Balloon System, which promotes fullness by placing a balloon in the stomach. These outpatient procedures help patients eat less, feel full faster, and recover quickly, providing a safe and effective option for moderate obesity or those ineligible for surgery, combined with lifestyle changes for comprehensive obesity management.

What Are Latest Mergers And Acquisitions In The Intragastric Balloons Market?

In April 2024, Opus Diagnostics, a Sweden-based technology company, entered a partnership with Gastric Balloon Group. The aim of the partnership between Opus Diagnostics and the Gastric Balloon Group is to provide a revolutionary, non-invasive weight loss solution to the Ascot and Berkshire communities. Gastric Balloon Group is a UK-based company that provides intragastric balloons for weight loss procedures.

Regional Outlook

North America was the largest region in the intragastric balloons market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Intragastric Balloons Market?

The intragastric balloons market consists of revenues earned by entities by providing services such as patient evaluation and consultation, nutritional counseling, diagnostic tests, balloon removal, post-removal support, monitoring and follow-up care, and behavioral support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The intragastric balloon market also includes sales of biodegradable intragastric balloons, and adjustable intragastric balloons. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.